Quadrant Capital Group LLC Aerie Pharmaceuticals Inc Transaction History

Quadrant Capital Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$6.37 - $15.23 $3,223 - $7,706	506 Added 538.3%	600 $9,000
Q2 2022 Aug 09, 2022	SELL	$4.95 - $9.16 $316 - $586	-64 Reduced 40.51%	94 $1,000
Q1 2022 May 06, 2022	BUY	$5.64 - $9.8 $891 - $1,548	158 New	158 $1,000
Q2 2020 Aug 13, 2020	SELL	$12.0 - $16.13 $1,272 - $1,709	-106 Closed	0 $0
Q3 2019 Oct 24, 2019	BUY	$18.41 - $28.0 $1,951 - $2,968	106 New	106 $2,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.